title: A Mycobacterium tuberculosis sigma factor network responds to cell-envelope damage by the promising anti-mycobacterial thioridazine.
abstract: BACKGROUND
  Novel therapeutics are urgently needed to control tuberculosis (TB). Thioridazine (THZ) is a candidate for the therapy of multidrug and extensively drug-resistant TB.
  
  
  RESULTS
  We studied the impact of THZ on Mycobacterium tuberculosis (Mtb) by analyzing gene expression profiles after treatment at the minimal inhibitory (1x MIC) or highly inhibitory (4x MIC) concentrations between 1-6 hours. THZ modulated the expression of genes encoding membrane proteins, efflux pumps, oxido-reductases and enzymes involved in fatty acid metabolism and aerobic respiration. The Rv3160c-Rv3161c operon, a multi-drug transporter and the Rv3614c/3615c/3616c regulon, were highly induced in response to THZ. A significantly high number of Mtb genes co-expressed with sigma(B) (the sigma(B) regulon) was turned on by THZ treatment. sigma(B) has recently been shown to protect Mtb from envelope-damage. We hypothesized that THZ damages the Mtb cell-envelope, turning on the expression of the sigma(B) regulon. Consistent with this hypothesis, we present electron-microscopy data which shows that THZ modulates cell-envelope integrity. Moreover, the Mtb mutants in sigma(H) and sigma(E), two alternate stress response sigma factors that induce the expression of sigma(B), exhibited higher sensitivity to THZ, indicating that the presence and expression of sigma(B) allows Mtb to resist the impact of THZ. Conditional induction of sigma(B) levels increased the survival of Mtb in the presence of THZ.
  
  
  CONCLUSIONS
  THZ targets different pathways and can thus be used as a multi-target inhibitor itself as well as provide strategies for multi-target drug development for combination chemotherapy. Our results show that the Mtb sigma factor network comprising of sigma(H), sigma(E) and sigma(B) plays a crucial role in protecting the pathogen against cell-envelope damage.
authors.affiliation: Division of Bacteriology and Parasitology, Tulane National Primate Research Center, Covington, Louisiana, United States of America.
authors.forename: Noton K
authors.initials: NK
authors.lastname: Dutta
authors.forename: Smriti
authors.initials: S
authors.lastname: Mehra
authors.forename: Deepak
authors.initials: D
authors.lastname: Kaushal
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology; D002473:Cell Wall / Q000187:drug effects*; D004305:Dose-Response Relationship, Drug; D020869:Gene Expression Profiling; D005786:Gene Expression Regulation / Q000187:drug effects; D005798:Genes, Bacterial / Q000187:drug effects; D007700:Kinetics; D009169:Mycobacterium tuberculosis / Q000187:drug effects* / Q000235:genetics* / Q000648:ultrastructure; D012808:Sigma Factor / Q000235:genetics*; D013881:Thioridazine / Q000494:pharmacology* / Q000627:therapeutic use
chemical_list: D000900:Anti-Bacterial Agents; D012808:Sigma Factor; D013881:Thioridazine
references.citation: Tuberculosis (Edinb). 2004;84(3-4):263-74
references.pmid: 15207496
references.citation: FEMS Microbiol Lett. 1992 Oct 1;76(1-2):73-6
references.pmid: 1427006
references.citation: Curr Drug Targets. 2008 Sep;9(9):816-9
references.pmid: 18781927
references.citation: Infect Immun. 2000 Oct;68(10):5575-80
references.pmid: 10992456
references.citation: Bioorg Med Chem Lett. 2007 Mar 1;17(5):1346-8
references.pmid: 17188865
references.citation: Infect Immun. 2003 Dec;71(12):7170-2
references.pmid: 14638810
references.citation: Metab Eng. 2002 Apr;4(2):182-92
references.pmid: 12009797
references.citation: Mol Microbiol. 1995 Jan;15(2):355-66
references.pmid: 7746156
references.citation: J Exp Med. 2003 Sep 1;198(5):693-704
references.pmid: 12953091
references.citation: Microb Pathog. 2001 May;30(5):271-8
references.pmid: 11373121
references.citation: Microbiology (Reading). 2007 Apr;153(Pt 4):1229-1242
references.pmid: 17379732
references.citation: Mol Microbiol. 2001 Jul;41(2):423-37
references.pmid: 11489128
references.citation: Int J Antimicrob Agents. 2001 Mar;17(3):225-8
references.pmid: 11282269
references.citation: J Bacteriol. 1992 Jun;174(12):3843-9
references.pmid: 1597408
references.citation: Proc Natl Acad Sci U S A. 1999 Oct 26;96(22):12833-8
references.pmid: 10536008
references.citation: J Immunol. 1999 Jun 1;162(11):6740-6
references.pmid: 10352293
references.citation: Antimicrob Agents Chemother. 2005 Nov;49(11):4778-80
references.pmid: 16251329
references.citation: J Antimicrob Chemother. 2007 Jun;59(6):1271-9
references.pmid: 17403708
references.citation: Proc Natl Acad Sci U S A. 2002 Jun 11;99(12):8330-5
references.pmid: 12060776
references.citation: Infect Immun. 1999 Sep;67(9):4931-4
references.pmid: 10456953
references.citation: J Biol Chem. 2006 Apr 28;281(17):11456-63
references.pmid: 16469750
references.citation: Mol Microbiol. 2010 Feb;75(3):538-42
references.pmid: 20025668
references.citation: J Biol Chem. 2004 Sep 17;279(38):40174-84
references.pmid: 15247240
references.citation: J Bacteriol. 2008 Jan;190(2):699-707
references.pmid: 17993538
references.citation: Bull World Health Organ. 2007 May;85(5):327
references.pmid: 17639210
references.citation: Mol Microbiol. 2002 Jul;45(2):365-74
references.pmid: 12123450
references.citation: Tuber Lung Dis. 1997;78(3-4):175-83
references.pmid: 9713650
references.citation: Mol Microbiol. 2010 Feb;75(3):592-606
references.pmid: 20025669
references.citation: Cell Host Microbe. 2007 Nov 15;2(5):352-64
references.pmid: 18005756
references.citation: Antimicrob Agents Chemother. 2008 Oct;52(10):3604-11
references.pmid: 18694955
references.citation: J Bacteriol. 2004 Feb;186(4):895-902
references.pmid: 14761983
references.citation: Antimicrob Agents Chemother. 2004 Jul;48(7):2415-23
references.pmid: 15215089
references.citation: J Bacteriol. 2009 Jun;191(12):3965-80
references.pmid: 19376862
references.citation: Proc Natl Acad Sci U S A. 2005 Mar 22;102(12):4548-53
references.pmid: 15767566
references.citation: Int J Antimicrob Agents. 2008 Mar;31(3):198-208
references.pmid: 18180147
references.citation: Antimicrob Agents Chemother. 2003 Mar;47(3):917-22
references.pmid: 12604522
references.citation: J Antimicrob Chemother. 1996 Jan;37(1):196-7
references.pmid: 8647767
references.citation: Antimicrob Agents Chemother. 2003 Sep;47(9):2903-13
references.pmid: 12936993
references.citation: J Antimicrob Chemother. 2008 Dec;62(6):1215-21
references.pmid: 18836185
references.citation: In Vivo. 2007 Sep-Oct;21(5):771-5
references.pmid: 18019410
references.citation: J Biol Chem. 2006 Feb 17;281(7):3866-75
references.pmid: 16354661
references.citation: J Bacteriol. 2005 Jun;187(12):4173-86
references.pmid: 15937179
references.citation: Int J Antimicrob Agents. 2007 Oct;30(4):336-40
references.pmid: 17644321
references.citation: Microbiology (Reading). 2009 Apr;155(Pt 4):1093-1102
references.pmid: 19332811
references.citation: Int J Antimicrob Agents. 2007 Mar;29(3):338-40
references.pmid: 17239569
references.citation: J Antimicrob Chemother. 2007 Jun;59(6):1237-46
references.pmid: 17218448
references.citation: Nature. 2008 Aug 7;454(7205):717-21
references.pmid: 18685700
references.citation: J Bacteriol. 2006 Jan;188(1):150-9
references.pmid: 16352831
references.citation: J Bacteriol. 2008 Apr;190(8):2981-6
references.pmid: 18296525
references.citation: Nat Rev Microbiol. 2008 Jan;6(1):41-52
references.pmid: 18079742
references.citation: J Bacteriol. 2009 Sep;191(18):5628-33
references.pmid: 19592585
references.citation: Mol Microbiol. 1998 Jun;28(6):1059-66
references.pmid: 9680198
references.citation: J Med Microbiol. 2009 Dec;58(Pt 12):1667-1668
references.pmid: 19696152
references.citation: Cell Microbiol. 2003 Sep;5(9):637-48
references.pmid: 12925133
references.citation: Proc Natl Acad Sci U S A. 1999 Sep 28;96(20):11554-9
references.pmid: 10500215